Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Smolen

Showing results (1-10 of 285) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|March 17, 2004
Combating the burden of musculoskeletal conditionsJ S Smolen
Wiener Klinische Wochenschrift|November 23, 1984
[Lyme disease--another tick-borne disease in Austria]J S Smolen
Scandinavian Journal of Rheumatology. Supplement|February 11, 2000
Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritisJ S Smolen
Annals of the Rheumatic Diseases|May 18, 2005
In the middle of the decadeJ S Smolen
British Journal of Rheumatology|April 1, 1992
The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)J S Smolen
Zeitschrift Fur Rheumatologie|April 13, 1999
[To the Christian-Georg-Schmorl-memorial lecture: 50 years of lupus erythemotosus cells]J S Smolen
Lupus|July 3, 2004
Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic interventionM Aringer, J S Smolen
Arthritis and Rheumatism|October 23, 2001
Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritisJ S Smolen, G Steiner
Rheumatology (Oxford, England)|December 7, 2002
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
Early arthritis. IntroductionT Pincus, J S Smolen
Pageof 29

Showing results (1-10 of 285) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|March 17, 2004
Combating the burden of musculoskeletal conditionsJ S Smolen
Wiener Klinische Wochenschrift|November 23, 1984
[Lyme disease--another tick-borne disease in Austria]J S Smolen
Scandinavian Journal of Rheumatology. Supplement|February 11, 2000
Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritisJ S Smolen
Annals of the Rheumatic Diseases|May 18, 2005
In the middle of the decadeJ S Smolen
British Journal of Rheumatology|April 1, 1992
The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)J S Smolen
Zeitschrift Fur Rheumatologie|April 13, 1999
[To the Christian-Georg-Schmorl-memorial lecture: 50 years of lupus erythemotosus cells]J S Smolen
Lupus|July 3, 2004
Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic interventionM Aringer, J S Smolen
Arthritis and Rheumatism|October 23, 2001
Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritisJ S Smolen, G Steiner
Rheumatology (Oxford, England)|December 7, 2002
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
Early arthritis. IntroductionT Pincus, J S Smolen
Pageof 29